Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.

April 27, 2017

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is bringing individual investors’ voices to Pfizer’s annual general meeting today in New Jersey to hold the pharmaceutical corporation accountable and demand it lowers the price of the pneumonia vaccine for all children in all developing countries.

April 25, 2017

DoD’s plans to grant an exclusive license to pharmaceutical company Sanofi on a vaccine candidate funded by the US government to combat Zika means there’s no guarantee that the vaccine will be developed, affordable or made available for those who need it most.

April 21, 2017

Over a weekend in March 2017, Doctors Without Borders/Médecins Sans Frontières (MSF) held its first Hackathon in New York City. More than 30 designers, strategists, and developers came together to build a tool to let individuals to use their power as investors or shareholders demand change from Pfizer and GlaxoSmithKline (GSK). Find out more at #AFairShot

April 20, 2017

Newsweek discusses a new online platform launched by Doctors Without Borders/Médecins Sans Frontières (MSF) that allows individuals in the United States to know whether they have investments in Pfizer and GSK through their mutual funds or retirements plans (401k) and, if so, contact those companies to insist they drop the price of lifesaving vaccines. View external media

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

March 08, 2017
WASHINGTON, MARCH 8, 2017—Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign manager and legal policy advisor, delivered the following remarks at the United States Trade Representative's 2017 Special 301 Review hearing today.
 
Good afternoon. I would like to provide testimony on behalf of MSF.

Pages